These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19209043)

  • 21. Indirect cost burden of migraine in the United States.
    Hawkins K; Wang S; Rupnow MF
    J Occup Environ Med; 2007 Apr; 49(4):368-74. PubMed ID: 17426520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Healthy Workplace Project: results of a hygiene-based approach to employee wellness.
    Thompson SJ; Rew L
    Am J Health Promot; 2015; 29(5):339-41. PubMed ID: 24670070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total costs of IBS: employer and managed care perspective.
    Cash B; Sullivan S; Barghout V
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-sectional study on the burden and impact of migraine on work productivity and quality of life in selected workplaces in the Philippines.
    Haw NJ; Cabaluna IT; Kaw GE; Cortez JF; Chua MP; Guce K
    J Headache Pain; 2020 Oct; 21(1):125. PubMed ID: 33109071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
    Láinez MJ; López A; Pascual AM
    Headache; 2005; 45(7):883-90. PubMed ID: 15985105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indirect costs of migraine in a public Brazilian hospital.
    Bigal ME; Moraes FA; Fernandes LC; Bordini CA; Speciali JG
    Headache; 2001 May; 41(5):503-8. PubMed ID: 11380649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic impact of migraine: an analysis of direct and indirect costs.
    Edmeads J; Mackell JA
    Headache; 2002 Jun; 42(6):501-9. PubMed ID: 12167138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic burden of lost productivity due to migraine headache: a specific worksite analysis.
    Burton WN; Conti DJ; Chen CY; Schultz AB; Edington DW
    J Occup Environ Med; 2002 Jun; 44(6):523-9. PubMed ID: 12085478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
    Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
    J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care utilization and disability of migraine: the Ontario Health Survey.
    To T; Wu K
    Can J Public Health; 1995; 86(3):195-9. PubMed ID: 7671207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine disorder: workplace implications and solutions.
    Berry PA
    AAOHN J; 2007 Feb; 55(2):51-6. PubMed ID: 17323870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Societal perspective on the burden of migraine in The Netherlands.
    van Roijen L; Essink-Bot ML; Koopmanschap MA; Michel BC; Rutten FF
    Pharmacoeconomics; 1995 Feb; 7(2):170-9. PubMed ID: 10155303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Lipton RB; Buse DC; Saiers J; Fanning KM; Serrano D; Reed ML
    Headache; 2013 Jan; 53(1):93-103. PubMed ID: 23148774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The family impact and costs of migraine.
    Stang PE; Crown WH; Bizier R; Chatterton ML; White R
    Am J Manag Care; 2004 May; 10(5):313-20. PubMed ID: 15152701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of migraine in the United States: disability and economic costs.
    Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
    Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of migraine in Brazil: estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care.
    Bigal ME; Rapoport AM; Bordini CA; Tepper SJ; Sheftell FD; Speciali JG
    Headache; 2003; 43(7):742-54. PubMed ID: 12890129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Migraine Nurses in Primary Care: Costs and Benefits.
    van den Berg JSP; Steiner TJ; Veenstra PJL; Kollen BJ
    Headache; 2017 Sep; 57(8):1252-1260. PubMed ID: 28524254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of productivity and resource utilization associated with epoetin alfa treatment in employees with predialysis chronic kidney disease.
    Papatheofanis F; Bookhart BK; Muser E; Piech CT
    J Occup Environ Med; 2008 May; 50(5):584-9. PubMed ID: 18469628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.